Brazil Veterinary Medicine Market To Reach $4.15 Billion By 2030

 

Brazil Veterinary Medicine Market Growth & Trends

The Brazil veterinary medicine market size is expected to reach USD 4.15 billion by 2030, registering a CAGR of 7.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising pet ownership rate, increased livestock production, and growing demand for advanced veterinary pharmaceuticals and vaccines drive market growth. Expanding government initiatives to improve animal health and the increasing presence of veterinary medicine providers further contribute to market expansion. Advancements in veterinary drug formulations and efforts to enhance disease prevention strategies are also supporting market growth. The growing emphasis on animal welfare and improved access to veterinary healthcare solutions is expected to drive further adoption of veterinary medicines across Brazil.

Brazil is one of the world’s largest exporters of beef and poultry, and this status encourages farmers to adopt rigorous health management practices, including regular veterinary care, vaccination, and disease prevention measures, to ensure high-quality animal protein output. According to the OECD, in 2023, Brazil's beef and veal meat consumption was projected to reach 18.1 kg per person, as compared to 17.8 kg per person in 2022. As demand for meat rises, livestock production scales up, requiring improved animal health practices to ensure meat quality and safety standards. Moreover, producers are motivated to invest in animal health to ensure that livestock remains free from diseases and meets the standards for both local consumption and export. This focus on preventive and therapeutic veterinary care further stimulates market growth as producers seek solutions to maintain animal welfare, improve feed efficiency, and reduce mortality rates.

Furthermore, the growth of veterinary healthcare facilities, including new animal clinics and specialized care centers, strengthens the Brazil Veterinary Medicine Market. Better access to veterinary services and improved diagnostic tools are helping detect diseases early and provide effective treatments. In addition, a stronger focus on sustainable livestock management and responsible use of antibiotics is driving the adoption of eco-friendly veterinary solutions. These trends are shaping the market and supporting its continued growth.

---

Request a free sample copy or view report summary: Brazil Veterinary Medicine Market Report

---

Brazil Veterinary Medicine Market Report Highlights

• By product, pharmaceuticals dominated the market with a share of 67.58% in 2024. However, the biologics segment is expected to grow at the highest CAGR of 8.8% during the forecast period. This growth is driven by increasing demand for vaccines and immunotherapies, along with advancements in biotechnology improving disease prevention and treatment in animals.

• By animal type, production animals held the largest market share in 2024, driven by the growing demand for livestock healthcare and disease management solutions. However, the companion animals segment is expected to grow at the fastest CAGR during the forecast period. This growth is supported by the rising pet population, increasing pet healthcare awareness, and a greater focus on preventive treatments for household animals.

• By route of administration, the injectable segment held the largest market share in 2024 due to its effectiveness in delivering fast-acting treatments for both companion and production animals. However, the other routes segment, including intranasal delivery, controlled-release implants, and transdermal patches, is expected to grow the most during the forecast period. This growth is driven by the increasing adoption of alternative drug delivery methods that enhance convenience, reduce animal stress, and improve treatment adherence.

• By distribution channel, veterinary hospitals and clinics held the largest market share in 2024. The e-commerce segment is expected to grow at the highest CAGR, driven by the convenience and accessibility of online veterinary products.

Brazil Veterinary Medicine Market Segmentation

Grand View Research has segmented the Brazil veterinary medicine market based on product, animal type, route of administration, and distribution channel:

Brazil Veterinary Medicine Product Outlook (Revenue, USD Million, 2018 - 2030)

• Biologics

  • Vaccines

    • Modified/ Attenuated Live

    • Inactivated (Killed)

    • Other Vaccines (subunit and DNA vaccines)

  • Other Biologics (monoclonal antibodies and regenerative medicine)

• Pharmaceuticals

  • Parasiticides

  • Anti-infectives

  • Anti-inflammatory

  • Analgesics

  • Others (cardiology, neurology, and hormone/fertility pharmaceuticals)

• Medicated Feed Additives

Brazil Veterinary Medicine Animal Type Outlook (Revenue, USD Million, 2018 - 2030)

• Production Animals

  • Poultry

  • Pigs

  • Cattle

  • Sheep & Goats

  • Others (aquaculture/fish, mules, camel, etc.)

• Companion Animals

  • Dogs

  • Cats

  • Horses

  • Others (small mammals, birds, rabbits, reptiles, etc.)

Brazil Veterinary Medicine Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)

• Oral

• Injectable

• Topical

• Other Routes (intranasal, controlled-release implants, etc.)

Brazil Veterinary Medicine Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Veterinary Hospitals & Clinics

• E-commerce

• Offline Retail Stores

• Others

List of Key Players in Brazil Veterinary Medicine Market

• Zoetis Services LLC

• Ceva

• Merck & Co., Inc.

• Vetoquinol

• Boehringer Ingelheim International GmbH.

• Elanco

• Virbac

• Phibro Animal Health Corporation

• Dechra Pharmaceuticals limited (Dechra Topco Limited)

• Bimeda, Inc.

• Biogénesis Bagó

• Ourofino Saúde Animal

• FARMABASE

• Vetnil

• Alivira Animal Health Limited

Sterile Bioprocess Filtration Market To Reach $15.45 Billion By 2030

Sterile Bioprocess Filtration Market Growth and Trends

The global sterile bioprocess filtration market size is anticipated to reach USD 15.45 billion by 2030 and is anticipated to grow at a CAGR of 19.10% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth is driven by the increasing demand for biologics, vaccines, cell and gene therapies, and stringent regulatory requirements for sterility assurance. Advancements in filtration technologies, the rise of single-use systems, and growing biopharmaceutical manufacturing investments further expand the market. Additionally, the increasing outsourcing of bioprocessing to CMOs and CROs, coupled with a surge in R&D activities, is fueling demand for high-performance sterile filtration solutions.

Furthermore, the rise of single-use systems accelerates market growth by enhancing process efficiency, reducing contamination risks, and lowering operational costs. Their increasing adoption in biopharmaceutical manufacturing, particularly in vaccine and biologics production, drives demand for advanced sterile filtration solutions. Single-use technologies offer flexibility, scalability, and compliance with stringent regulatory standards, making them a preferred choice for manufacturers. As the industry shifts toward cost-effective and high-efficiency filtration processes, the demand for single-use filtration systems is expected to grow significantly over the forecast period.

In addition, the growing demand for biologics, vaccines, and cell and gene therapies is fueling the expansion of the sterile bioprocess filtration market. With rising R&D investments and stringent regulatory requirements, manufacturers are adopting advanced filtration technologies to ensure sterility and product safety. The increasing prevalence of chronic diseases and the shift toward personalized medicine further drive market growth. Additionally, the expansion of biopharmaceutical manufacturing facilities and the adoption of single-use filtration systems contribute to the sector’s rapid development, positioning sterile filtration as a critical component in bioprocessing.

Despite the strong market growth, the high costs associated with sterile filtration systems and stringent regulatory approvals pose significant challenges. The complex validation processes required for sterility assurance increase both time and investment for manufacturers. The limited reusability of single-use systems raises concerns about long-term cost efficiency and environmental impact. Supply chain disruptions and technical challenges in large-scale bioprocessing further hinder market expansion. Overcoming these restraints will require continuous innovation, cost optimization strategies, and regulatory streamlining to ensure sustained growth in the sterile bioprocess filtration market.

---

Request a free sample copy or view report summary: Sterile Bioprocess Filtration Market Report

---

Sterile Bioprocess Filtration Market Report Highlights

• Membrane filters dominated the product segment in 2024 owing to their high efficiency, reliability, and widespread use in biopharmaceutical filtration. However, cartridge filters are anticipated to grow at the fastest CAGR over the forecast period.

• The upstream held the largest revenue share in 2024 for the workflow segment, driven by increasing demand for sterile filtration in cell culture, media preparation, and fermentation processes. On the other hand, the aseptic filling segment is anticipated to witness the fastest CAGR over the forecast period.

• The polyethersulfone (PES) segment in material led the market in 2024, owing to its superior chemical resistance, high flow rates, and strong membrane integrity in biopharmaceutical filtration. On the other hand, polyvinylidene fluoride (PVDF) is expected to grow at the fastest CAGR during the forecast period.

• The biopharmaceutical & biotechnology companies segment held the largest revenue share in 2024. The growth is due to rising demand for biologics, increased R&D investments, and stringent sterility regulations in drug manufacturing. On the other hand, the CMOs & CROs segment is expected to register the fastest growth rate during the projected period.

• North America dominated the sterile bioprocess filtration market owing to factors such as a strong biopharmaceutical industry, high R&D investments, advanced healthcare infrastructure, and stringent regulatory standards for sterility assurance. Asia Pacific is expected to grow at the fastest CAGR during the forecast period.

Sterile Bioprocess Filtration Market Segmentation

Grand View Research has segmented the global sterile bioprocess filtration market report based on product, workflow, material, end use, and region:

Sterile Bioprocess Filtration Product Outlook (Revenue, USD Million, 2018 - 2030)

• Membrane Filters

• Depth Filters

• Cartridge Filters

• Capsule Filters

• Filtration Accessories

• Other Sterile Filters

Sterile Bioprocess Filtration Workflow Outlook (Revenue, USD Million, 2018 - 2030)

• Upstream

• Downstream

• Fermentation

• Aseptic Filling

Sterile Bioprocess Filtration Material Outlook (Revenue, USD Million, 2018 - 2030)

• Polyethersulfone (PES)

• Polyvinylidene Fluoride (PVDF)

• Polytetrafluoroethylene (PTFE)

• Nylon

• Other Materials

Sterile Bioprocess Filtration End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Biopharmaceutical & Biotechnology Companies

• CMOs & CROs

• Academic & Research Institutes

Veterinary Hematology Analyzers Market To Reach $2.12 Billion By 2030

Veterinary Hematology Analyzers Market Growth & Trends

The global veterinary hematology analyzers market size is anticipated to reach USD 2.12 billion by 2030 and is projected to grow at a CAGR of 10.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by growing animal population and ownership rates, increased expenditure on animals, an increasing focus on preventative animal healthcare, advances in veterinary molecular diagnostic testing, and rising R&D investment in animal health diagnostics to launch innovative products. For instance, in January 2024, Center Point Bio-Tech (CPB) launched AlphaION, a next-generation veterinary diagnostic system, at the 2024 Veterinary Meeting & Expo, exceeding order expectations. AlphaION combines lab automation, AI, and modular components for streamlined blood, fecal, urine, and bacterial testing at the point of care. Future developments include holographic cell reconstruction for enhanced hematology accuracy, eliminating reagent packs, and reducing maintenance needs.

The rising prevalence of animal diseases and growing pet ownership drive the veterinary hematology analyzers industry. According to the World Organisation for Animal Health (WOAH), over 20% of livestock losses globally are due to diseases, increasing the need for early and accurate diagnostic testing. In addition, the surge in companion animal ownership, with nearly 70% of U.S. households owning pets, drives the demand for advanced diagnostic tools in veterinary clinics. The increasing focus on preventive healthcare and regular wellness screenings further boosts the adoption of hematology analyzers for early disease detection and monitoring.

The growing demand for accurate and rapid diagnostics is boosting the adoption of 5-part analyzers in specialty veterinary laboratories. Veterinary hematology analyzers play a key role in conducting CBC tests to monitor animal health by analyzing RBC, PLT, and WBC counts. While 3-part analyzers are cost-effective and sufficient for general screenings, 5-part analyzers offer enhanced accuracy by differentiating WBC into five subtypes, making them ideal for complex cases. 4-part analyzers provide a balance, offering eosinophil differentiation without the higher cost of 5-part devices. Advanced models, like Boule’s Exigo H400, combine low maintenance, cost efficiency, and high accuracy, making them suitable for veterinary clinics and labs.

Key market trends include automation, point-of-care testing (POCT), and multi-parameter analysis. The shift towards POCT analyzers that deliver real-time results is gaining traction, allowing veterinarians to make faster clinical decisions. Moreover, the development of compact, portable hematology analyzers with enhanced sensitivity and specificity is expanding their adoption in rural and mobile veterinary practices. As AI and machine learning continue to refine diagnostic accuracy, the veterinary hematology analyzer industry is expected to witness sustained growth, driven by demand for rapid, accurate, and cost-effective diagnostics.

---

Request a free sample copy or view report summary: 
Veterinary Hematology Analyzers Market Report

---

Veterinary Hematology Analyzers Market Report Highlights

• The Point-of-care analyzers segment led the market with the largest revenue share of 61.45% in 2024, due to rapid diagnostics, ease of use, and growing demand for on-site testing. It is expected to grow at the fastest CAGR of 10.4% during the forecast period, driven by rising veterinary clinics and improved patient outcomes.

• Based on species, the canine segment accounted for the largest market revenue share in 2024, due to the high prevalence of canine diseases, increasing pet ownership, and frequent diagnostic testing. However, the feline segment is projected to grow at the fastest CAGR from 2025 to 2030, owing to rising feline adoption rates, growing awareness of feline health, and increased veterinary expenditures on cats.

• Based on analysis parameters, the 5-part WBC differential segment accounted for the largest market revenue share in 2024, due to its greater accuracy and detailed leukocyte analysis, aiding in the precise diagnosis of complex diseases. The other parameters segment is projected to grow at the fastest CAGR during the forecast period, due to rising demand for advanced diagnostic capabilities, including reticulocyte counts and nucleated red blood cells, enhancing disease detection accuracy.

• Based on end use, the veterinary laboratories segment accounted for the largest market revenue share in 2024, owing to the high testing volume, advanced diagnostic capabilities, and access to skilled professionals, ensuring accurate and comprehensive results. Conversely, the Point-Of-Care Testing (POCT) segment is expected to grow at the highest CAGR due to its rapid turnaround time, convenience, and increasing adoption of portable analyzers for immediate on-site diagnostics.

• North America dominated the market with the largest revenue share of 52.85% in 2024. Conversely, the Asia Pacific region is anticipated to grow at the fastest CAGR of 12.7% during the forecast period.

• Increasing pet insurance coverage and rising expenditure on animal healthcare drive the demand for advanced veterinary diagnostics, creating growth opportunities for veterinary hematology analyzers.

Veterinary Hematology Analyzers Market Segmentation

Grand View Research has segmented the global veterinary hematology analyzers market report based on product, species, analysis parameters, end-use, and region:

Veterinary Hematology Analyzers Product Outlook (Revenue, USD Million; 2018 - 2030)

• Table-top analyzers        

  • Fully automatic analyzers

  • Semi-automatic analyzers

• Point-of-care analyzers

  • Cartridge based analyzers

  • Direct sample-based analyzers

Veterinary Hematology Analyzers Species Outlook (Revenue, USD Million; 2018 - 2030)

• Cattle

• Canine

• Feline

• Caprine

• Equine

• Ovine

• Porcine

• Avian

• Others

Veterinary Hematology Analysis Parameters Outlook (Revenue, USD Million; 2018 - 2030)

• 3-part WBC differential

• 5-part WBC differential

• Other parameters

Veterinary Hematology Analyzers End-use Outlook (Revenue, USD Million; 2018 - 2030)

• Veterinary Laboratories

• Veterinary Hospitals and Clinics

• Point-Of-Care Testing

• Others

Veterinary Hematology Analyzers Market To Reach $2.12 Billion By 2030

 

Veterinary Hematology Analyzers Market Growth & Trends

The global veterinary hematology analyzers market size is anticipated to reach USD 2.12 billion by 2030 and is projected to grow at a CAGR of 10.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by growing animal population and ownership rates, increased expenditure on animals, an increasing focus on preventative animal healthcare, advances in veterinary molecular diagnostic testing, and rising R&D investment in animal health diagnostics to launch innovative products. For instance, in January 2024, Center Point Bio-Tech (CPB) launched AlphaION, a next-generation veterinary diagnostic system, at the 2024 Veterinary Meeting & Expo, exceeding order expectations. AlphaION combines lab automation, AI, and modular components for streamlined blood, fecal, urine, and bacterial testing at the point of care. Future developments include holographic cell reconstruction for enhanced hematology accuracy, eliminating reagent packs, and reducing maintenance needs.

The rising prevalence of animal diseases and growing pet ownership drive the veterinary hematology analyzers industry. According to the World Organisation for Animal Health (WOAH), over 20% of livestock losses globally are due to diseases, increasing the need for early and accurate diagnostic testing. In addition, the surge in companion animal ownership, with nearly 70% of U.S. households owning pets, drives the demand for advanced diagnostic tools in veterinary clinics. The increasing focus on preventive healthcare and regular wellness screenings further boosts the adoption of hematology analyzers for early disease detection and monitoring.

The growing demand for accurate and rapid diagnostics is boosting the adoption of 5-part analyzers in specialty veterinary laboratories. Veterinary hematology analyzers play a key role in conducting CBC tests to monitor animal health by analyzing RBC, PLT, and WBC counts. While 3-part analyzers are cost-effective and sufficient for general screenings, 5-part analyzers offer enhanced accuracy by differentiating WBC into five subtypes, making them ideal for complex cases. 4-part analyzers provide a balance, offering eosinophil differentiation without the higher cost of 5-part devices. Advanced models, like Boule’s Exigo H400, combine low maintenance, cost efficiency, and high accuracy, making them suitable for veterinary clinics and labs.

Key market trends include automation, point-of-care testing (POCT), and multi-parameter analysis. The shift towards POCT analyzers that deliver real-time results is gaining traction, allowing veterinarians to make faster clinical decisions. Moreover, the development of compact, portable hematology analyzers with enhanced sensitivity and specificity is expanding their adoption in rural and mobile veterinary practices. As AI and machine learning continue to refine diagnostic accuracy, the veterinary hematology analyzer industry is expected to witness sustained growth, driven by demand for rapid, accurate, and cost-effective diagnostics.

Request a free sample copy or view report summary:
Veterinary Hematology Analyzers Market Report

Veterinary Hematology Analyzers Market Report Highlights

• The Point-of-care analyzers segment led the market with the largest revenue share of 61.45% in 2024, due to rapid diagnostics, ease of use, and growing demand for on-site testing. It is expected to grow at the fastest CAGR of 10.4% during the forecast period, driven by rising veterinary clinics and improved patient outcomes.
• Based on species, the canine segment accounted for the largest market revenue share in 2024, due to the high prevalence of canine diseases, increasing pet ownership, and frequent diagnostic testing. However, the feline segment is projected to grow at the fastest CAGR from 2025 to 2030, owing to rising feline adoption rates, growing awareness of feline health, and increased veterinary expenditures on cats.
• Based on analysis parameters, the 5-part WBC differential segment accounted for the largest market revenue share in 2024, due to its greater accuracy and detailed leukocyte analysis, aiding in the precise diagnosis of complex diseases. The other parameters segment is projected to grow at the fastest CAGR during the forecast period, due to rising demand for advanced diagnostic capabilities, including reticulocyte counts and nucleated red blood cells, enhancing disease detection accuracy.
• Based on end use, the veterinary laboratories segment accounted for the largest market revenue share in 2024, owing to the high testing volume, advanced diagnostic capabilities, and access to skilled professionals, ensuring accurate and comprehensive results. Conversely, the Point-Of-Care Testing (POCT) segment is expected to grow at the highest CAGR due to its rapid turnaround time, convenience, and increasing adoption of portable analyzers for immediate on-site diagnostics.
• North America dominated the market with the largest revenue share of 52.85% in 2024. Conversely, the Asia Pacific region is anticipated to grow at the fastest CAGR of 12.7% during the forecast period.
• Increasing pet insurance coverage and rising expenditure on animal healthcare drive the demand for advanced veterinary diagnostics, creating growth opportunities for veterinary hematology analyzers.

Veterinary Hematology Analyzers Market Segmentation

Grand View Research has segmented the global veterinary hematology analyzers market report based on product, species, analysis parameters, end-use, and region:

Veterinary Hematology Analyzers Product Outlook (Revenue, USD Million; 2018–2030)

• Table-top analyzers
• Fully automatic analyzers
• Semi-automatic analyzers
• Point-of-care analyzers
• Cartridge based analyzers
• Direct sample-based analyzers

Veterinary Hematology Analyzers Species Outlook (Revenue, USD Million; 2018–2030)

• Cattle
• Canine
• Feline
• Caprine
• Equine
• Ovine
• Porcine
• Avian
• Others

Veterinary Hematology Analysis Parameters Outlook (Revenue, USD Million; 2018–2030)

• 3-part WBC differential
• 5-part WBC differential
• Other parameters

Veterinary Hematology Analyzers End-use Outlook (Revenue, USD Million; 2018–2030)

• Veterinary Laboratories
• Veterinary Hospitals and Clinics
• Point-Of-Care Testing
• Others

DNA Barcoding Services Market To Reach $357.5 Million By 2030

 

DNA Barcoding Services Market Growth & Trends

The global DNA barcoding services market size is expected to reach USD 357.5 million by 2030 and is projected to grow at 11.47% CAGR from 2025 to 2030, according to a new report by Grand View Research, Inc. The market has experienced considerable growth due to its increasing application across various industries such as agriculture, food safety, environmental conservation, and pharmaceuticals.

One of the key drivers for this market is the rising demand for precise species identification in food safety and quality control. As consumers demand more transparency in food sourcing, especially in seafood and herbal products, DNA barcoding has become an essential tool for detecting food fraud, ensuring authenticity, and preventing contamination. This trend is further amplified by the increasing regulatory pressure to maintain stringent food safety standards, which drives the adoption of DNA barcoding services across global food industries.

The impact of COVID-19 on the DNA barcoding services industry has been multifaceted. During the pandemic, there was a surge in demand for accurate diagnostic tools and research on viral pathogens. DNA barcoding services became increasingly valuable in the identification of novel pathogens and the monitoring of emerging infectious diseases. In addition, with the rise of remote work and research, many institutions and businesses began relying more on bioinformatics platforms and online DNA sequencing services, further driving the adoption of DNA barcoding. Despite initial disruptions to research activities, the pandemic highlighted the importance of genomic technologies in both health and environmental sectors, fueling continued investment in DNA barcoding services.

The growing importance of environmental monitoring and biodiversity conservation has also significantly contributed to the demand for DNA barcoding services. Governments and conservation organizations are increasingly using DNA barcoding for ecological studies and species tracking, particularly in biodiversity hotspots. These services enable researchers to monitor endangered species and identify invasive species with greater accuracy, supporting conservation efforts. The ability to track genetic diversity in various ecosystems using DNA barcoding is crucial in understanding the impacts of climate change and human activities on global biodiversity, making it an essential tool for environmental protection.

In addition, the ongoing advancements in sequencing technologies have bolstered the growth of the market. New methods, such as next-generation sequencing (NGS) and high-throughput sequencing, have significantly improved the accuracy, efficiency, and affordability of DNA barcoding. These technological advancements have allowed for large-scale biodiversity studies, better pathogen detection, and more precise tracking of agricultural pests and diseases. The combination of cutting-edge technologies and a growing need for genomic data in various industries ensures that DNA barcoding services remain integral to research and commercial applications, positioning the market for continued expansion in the post-pandemic era.

Request a free sample copy or view report summary:
DNA Barcoding Services Market Report

DNA Barcoding Services Market Report Highlights

• By type, the microbial DNA barcoding services segment accounted for the largest revenue share of 43.99%. The market is driven by increasing demand for accurate microbial identification in various sectors such as healthcare, agriculture, and environmental research.
• By method, the long-read sequencing segment is expected to register the fastest CAGR during the forecast period. The integration of long-read sequencing with AI-driven analysis tools is improving data interpretation accelerating discoveries in ecological research, food safety, and forensic applications.
• By application, the product authentication and quality control segment is expected to register the fastestCAGR during the forecast period. The market is driven by the rising demand for traceability solutions in global trade, boosting the adoption of DNA barcoding to authenticate high-value goods such as seafood, meat products, and luxury items growth.
• By end use, the pharmaceutical & biotechnology companies segment dominated the market and accounted for the largest revenue share in 2024. The market is driven by continuous advancements in sequencing technologies and bioinformatics tools have enhanced the speed, accuracy, and cost-efficiency of DNA barcoding services, making them increasingly attractive to pharmaceutical and biotech firms.
• North America held the largest revenue share globally at 42.75% in 2024. The growing interest in biodiversity conservation and environmental monitoring also contributes to market growth as researchers utilize DNA barcoding for ecosystem studies. In addition, advancements in genomic technologies and regulatory pressure to maintain high standards in agriculture and pharmaceuticals are key factors. The COVID-19 pandemic further accelerated the adoption of DNA barcoding in pathogen detection and diagnostics, reinforcing its value in public health.

DNA Barcoding Services Market Segmentation

Grand View research has segmented the global DNA barcoding services market based on type, method, application, end-use, and region:

DNA Barcoding Services Type Outlook (Revenue, USD Billion, 2018–2030)

• Plant DNA Barcoding Services
• Animal DNA Barcoding Services
• Microbial DNA Barcoding Services

DNA Barcoding Services Method Outlook (Revenue, USD Billion, 2018–2030)

• Sanger Sequencing
• Short Read Sequencing
• Long Read Sequencing

DNA Barcoding Services Application Outlook (Revenue, USD Billion, 2018–2030)

• Pathogen Identification and Monitoring
• Product Authentication and Quality Control
• Biodiversity and Conservation Monitoring
• Forensic and Legal Investigations
• Others

DNA Barcoding Services End-use Outlook (Revenue, USD Billion, 2018–2030)

• Pharmaceutical & Biotechnology Companies
• Agriculture and Food Industry
• Academic & Research Institutes
• Others